Use of simulated sputum specimens to estimate the specificity of laboratory-diagnosed tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 8, 2010, Pages 1016-1023

  Demers, A M ^a   Boulle, A ^b   Warren, R ^c   Verver, S ^d,e   Van Helden, P ^c   Behr, Marcel A ^f   Coetzee, D ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

^d KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Cross contamination; Quality assurance; Simulated sputum; Tuberculosis

Indexed keywords

ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; FALSE POSITIVE RESULT; HEALTH CENTER; HUMAN; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SIMULATION; SOUTH AFRICA; SPUTUM; SPUTUM ANALYSIS; TUBERCULOSIS; ADOLESCENT; COMPARATIVE STUDY; COMPUTER SIMULATION; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; HEALTH CARE QUALITY; INCIDENCE; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MICROBIOLOGY; UTILIZATION;

ADOLESCENT; COMPUTER SIMULATION; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; HUMANS; INCIDENCE; MYCOBACTERIUM TUBERCULOSIS; QUALITY ASSURANCE, HEALTH CARE; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM; TUBERCULOSIS;

EID: 77954701086     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Burman W J, Reves R R. Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin Infect Dis 2000; 31: 1390-1395.
2. Small P M, McClenny N B, Singh S P, Schoolnik G K, Tompkins L S, Mickelsen P A. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol 1993; 31: 1677-1682.
3. Braden C R, Templeton G L, Stead W W, Bates J H, Cave M D, Valway S E. Retrospective detection of laboratory cross-contamination of Mycobacterium tuberculosis cultures with use of DNA fingerprint analysis. Clin Infect Dis 1997; 24: 35-40.
4. de Boer A S, Blommerde B, de Haas P E, et al. False-positive Mycobacterium tuberculosis cultures in 44 laboratories in The Netherlands (1993 to 2000): incidence, risk factors, and consequences. J Clin Microbiol 2002; 40: 4004-4009.
5. Aziz M A, Ba F, Becx-Bleumink M, et al. External quality assessment for AFB smear microscopy. PHL, CDC, IUATLD, KNCV, RIT, and WHO. Washington DC, USA: Association of Public Health Laboratories, 2003.
6. de Kantor I N, Kim S J, Frieden T R, et al. Laboratory services in tuberculosis control. Organization and management. Part I. WHO/TB/98.258. Geneva, Switzerland: World Health Organization, 1998.
7. Steingart K R, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6: 570-581. (Pubitemid 44262344)
8. Aber V R, Allen B W, Mitchison D A, Ayuma P, Edwards E A, Keyes A B. Quality control in tuberculosis bacteriology. 1. Laboratory studies on isolated positive cultures and the efficiency of direct smear examination. Tubercle 1980; 61: 123-133.
9. Rieder H L. Epidemiologic basis of tuberculosis control. Paris, France: International Union Against Tuberculosis and Lung Disease, 1999.
10. Kubica G P. Correlation of acid-fast staining methods with culture results for mycobacteria. Bull Int Union Tuberc 1980; 55(3-4): 117-124.
11. Lipsky B A, Gates J, Tenover F C, Plorde J J. Factors affecting the clinical value of microscopy for acid-fast bacilli. Rev Infect Dis 1984; 6: 214-222.
12. Van Deun A, Portaels F. Limitations and requirements for quality control of sputum smear microscopy for acid-fast bacilli. Int J Tuberc Lung Dis 1998; 2: 756-765. (Pubitemid 28429727)
13. Kinyanjui M G, Githui W A, Kamunyi R G, Omwega M J, Waiyaki P G, Muthami L N. Quality control in the laboratory diagnosis of tuberculosis. East Afr Med J 1991; 68: 3-9.
14. Gruft H, Loder A, Osterhout M. A mycobacteriology proficiency testing program using simulated sputum specimens. Health Lab Sci 1976; 13: 184-189. (Pubitemid 8201125)
15. Saceanu C A, Pfeiffer N C, McLean T. Evaluation of sputum smears concentrated by cytocentrifugation for detection of acid-fast bacilli. J Clin Microbiol 1993; 31: 2371-2374. (Pubitemid 23254203)
16. Tablan O C, Carson L A, Cusick L B, Bland L A, Martone W J, Jarvis W R. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol 1987; 25: 485-487.
17. Whittier S, Olivier K, Gilligan P, Knowles M, Della-Latta P. Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. J Clin Microbiol 1997; 35: 2706-2708. (Pubitemid 27402696)
18. Mitchison D A, Keyes A B, Edwards E A, Ayuma P, Byfield S P, Nunn A J. Quality control in tuberculosis bacteriology. 2. The origin of isolated positive cultures from the sputum of patients in four studies of short course chemotherapy in Africa. Tubercle 1980; 61: 135-144.
19. Hong Kong Chest Service/Tuberculosis Research Centre Madras British Medical Research Council. A study of the characteristics and course of sputum smear-negative pulmonary tuberculosis. Tubercle 1981; 62: 155-167.
20. Burdz T V N, Wolfe J, Kabani A. Evaluation of sputum decontamination methods for Mycobacterium tuberculosis using viable colony counts and fl ow cytometry. Diagn Microbiol Infect Dis 2003; 47: 503-509. (Pubitemid 37338515)
21. Yamada H, Mitarai S, Aguiman L, Matsumoto H, Fujiki A. Preparation of mycobacteria-containing artificial sputum for TB panel testing and microscopy of sputum smears. Int J Tuberc Lung Dis 2006; 10: 899-905. (Pubitemid 44197851)
22. Hanley J A, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 1983; 249: 1743-1745.
23. Toman K. What are the main causes of false-positive and false-negative sputum smears? In: Frieden T R, ed. Toman's tuberculosis. Case detection, treatment and monitoring. WHO/HTM/TB/2004.334. 2nd ed. Geneva, Switzerland: World Health Organization, 2004: pp 23-27.
24. Fitzpatrick L, Braden C, Cronin W, et al. Investigation of laboratory cross-contamination of Mycobacterium tuberculosis cultures. Clin Infect Dis 2004; 38: e52-e54.
25. Schoch O D, Pfyffer G E, Buhl D, Paky A. False-positive Mycobacterium tuberculosis culture revealed by restriction fragment length polymorphism analysis. Infection 2003; 31: 189-191. (Pubitemid 36737045)
26. Jasmer R M, Roemer M, Hamilton J, et al. A prospective, multicenter study of laboratory cross-contamination of Mycobacterium tuberculosis cultures. Emerg Infect Dis 2002; 8: 1260-1263. (Pubitemid 35334698)
27. Carroll N M, Richardson M, Engelke E, de Kock M, Lombard C, van Helden P D. Reduction of the rate of false-positive cultures of Mycobacterium tuberculosis in a laboratory with a high culture positivity rate. Clin Chem Lab Med 2002; 40: 888-892. (Pubitemid 35277414)
28. van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341: 1174-1179. (Pubitemid 29480655)
29. van Rie A, Warren R, Richardson M, et al. Classification of drug-resistant tuberculosis in an epidemic area. Lancet 2000; 356: 22-25. (Pubitemid 30416990)
30. Verver S, Warren R M, Munch Z, et al. Transmission of tuberculosis in a high incidence urban community in South Africa. Int J Epidemiol 2004; 33: 351-357. (Pubitemid 38578835)
31. World Health Organization. New WHO Policies. Definition of a new sputum smear-positive TB case. Geneva, Switzerland: WHO. http://www.who.int/tb/dots/ laboratory/policy/en/index1.html Accessed May 2010.